National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs.

Autor: Lahue BJ; Vice President, Health Economics and Outcomes Research, Becton, Dickinson and Company, Franklin Lakes, NJ., Pyenson B; Principal, Consulting Actuary, Milliman Inc, New York, NY., Iwasaki K; Consulting Actuary, Milliman Inc, New York, NY., Blumen HE; Principal, Senior Health Consultant, Milliman Inc, New York, NY., Forray S; Consulting Actuary at Milliman Inc, New York, NY., Rothschild JM; Associate Professor of Medicine, Division of General Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Publikováno v: American health & drug benefits [Am Health Drug Benefits] 2012 Nov; Vol. 5 (7), pp. 1-10.